👥 Sartorius will contribute its engineering and manufacturing expertise to commercialize ICB platforms based on prototypes developed by Sanofi.
📜 In return, Sanofi will grant Sartorius exclusive access to its know-how and patents related to the ICB platform.
🌍 The collaboration aims to reduce the cost of drug manufacturing and improve the environmental footprint of operations.
🚀 The platform will combine flexibility with the advantages of intensified bioprocessing to get life-saving drugs to patients faster.
💼 Integrated continuous biomanufacturing maximizes efficiency by enabling uninterrupted and steady materials flow.
🏭 ICB reduces the overall process footprint, leading to lower raw material and energy consumption, higher productivity, and less waste.
Introduction:
Sartorius has announced a collaboration with Sanofi to develop an integrated and continuous downstream bioprocessing (ICB) platform. This collaboration aims to improve the cost-effectiveness and environmental impact of biopharmaceutical production.
- Sartorius will collaborate with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing (ICB).
- Sartorius will contribute its engineering and manufacturing expertise to commercialize ICB platforms based on prototypes developed by Sanofi.
- Sanofi will grant Sartorius exclusive access to its know-how and patents related to the ICB platform.
- Integrated continuous biomanufacturing aims to maximize efficiency by enabling uninterrupted and steady materials flow, leading to lower raw material and energy consumption, higher productivity, and less waste.
- This collaboration will provide biopharmaceutical companies with a unique modular platform that combines flexibility with the advantages of intensified bioprocessing.
Conclusion:
The collaboration between Sartorius and Sanofi aims to develop an integrated and continuous downstream bioprocessing platform, improving the efficiency and sustainability of biopharmaceutical production. This collaboration will contribute to reducing the cost of drug manufacturing and ensuring faster access to life-saving medications.
